Mar 15, 2022 / 01:30PM GMT
Luke England Sergott - Barclays Bank PLC, Research Division - Research Analyst
I think we're ready to go. Good morning, everybody. I'm Luke Sergott from Barclays. I cover life science tools and diagnostics. It's my pleasure to have Kevin Herde from Maravai. And we're going to pretty much start on the macro here, but then we can get into some of the core business and some of the other drivers.
Questions and Answers:
Luke England Sergott - Barclays Bank PLC, Research Division - Research AnalystSo with that, just give us an update on -- as we go from Ukraine, Russia, limited exposure, obviously, but I've been asking everybody if they're seeing anything from weakness in demand trends or anything else overall spilling over.
Kevin M. Herde - Maravai LifeSciences Holdings, Inc. - Executive VP & CFO
Yes. Great. Well, first of all, thanks, Luke, for having us here. It's nice to be out of the office and see all of you in person.
Specifically with regards to that region, yes, very limited exposure, no